In 2025, US Biotech stocks are expected to rise significantly. jpmorgan's top pick is vertex pharmaceuticals (VRTX.US).

Vertex pharmaceuticals (Vertex) ranked first on the list of US biotechnology stock selections for 2025 released by jpmorgan.

Zhitong FinanceNov 26 02:22 ET

Insider Sale: SVP of $TVTX (TVTX) Sells 12,090 Shares

Quiver QuantitativeNov 25 21:15 ET

Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025

Seeking AlphaNov 25 15:10 ET

JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG

Seeking AlphaNov 25 13:58 ET

Travere Therapeutics (TVTX) Gets a Buy From J.P. Morgan

TipRanksNov 21 07:05 ET · Ratings

Express News | Travere Therapeutics Inc : JP Morgan Cuts Target Price to $42 From $43

ReutersNov 20 00:28 ET